Patents by Inventor Irina Balan

Irina Balan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240276551
    Abstract: Examples of the present disclosure provide apparatuses, methods and computer programs for controlling the storage and/or transmission of RA reports. Certain examples provide an apparatus comprising: means for receiving information indicative of a criterion for determining, at least in part, whether a Random Access (RA) report is to be stored and/or transmitted; means for controlling a storage and/or a transmission of the RA report based, at least in part, on the indicated criterion; wherein the criterion is based, at least in part, on a RA configuration associated with the RA report, and wherein the RA configuration comprises RA configuration information for a RA procedure that has been performed and whose information has been logged in the RA report.
    Type: Application
    Filed: December 26, 2023
    Publication date: August 15, 2024
    Inventors: Ling YU, Irina BALAN, Anna PANTELIDOU, Malgorzata TOMALA, György WOLFNER, Hakon HELMERS
  • Publication number: 20230239752
    Abstract: According to an example embodiment, a method may include logging, by a user device in a wireless network, information related to a multiple-event conditional handover execution, wherein the multiple-event conditional handover execution is based on a joint evaluation of multiple events by the user device; and sending, by the user device, a report including at least a portion of the information.
    Type: Application
    Filed: May 21, 2021
    Publication date: July 27, 2023
    Inventors: Irina Balan, Ahmad Awada, Richard Waldhauser, Guillaume Decarreau, Ingo Viering
  • Publication number: 20210205329
    Abstract: Methods of inhibiting proinflammatory neuroimmune signaling as is related to the treatment of inflammatory disorders are provided. These methods include the inhibiting of toll-like receptor signaling and/or the enhancement of anti-inflammatory signaling, and in one example, the inhibiting of TLR2, TLR4 or TLR7 signaling as well as the enhancement of fracktalkine or IL-10 signaling either alone or together.
    Type: Application
    Filed: May 20, 2019
    Publication date: July 8, 2021
    Inventors: A. Leslie Morrow, Laure Aurelian, Irina Balan